Mustang Bio, Inc. (MBIO) Financials

MBIO Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2023 17.7 million 17.6 million
Sept. 30, 2023 20.6 million 16.6 million
June 30, 2023 29.1 million 15.4 million
March 31, 2023 73.6 million 43.8 million

MBIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 -7.3 million 188000
Sept. 30, 2023 -12.1 million 100000
June 30, 2023 -12.4 million 45000
March 31, 2023 -17.8 million 235000

MBIO Net Income

No data available :(

MBIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 6.2 million - 2.5 million
Sept. 30, 2023 9.6 million - 2.6 million
June 30, 2023 15.4 million - 2.6 million
March 31, 2023 58.1 million 27.6 million 3.9 million

MBIO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2023 9.2 million
Sept. 30, 2023 8.2 million
June 30, 2023 8.1 million
March 31, 2023 8.1 million

MBIO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 30000 6.4 million 2.2 million 79000
Sept. 30, 2023 50000 9.5 million 2.1 million -
June 30, 2023 34000 10.8 million 3.1 million -
March 31, 2023 18000 14.0 million 2.3 million -

MBIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 - 363000
Sept. 30, 2023 - 1.4 million
June 30, 2023 - 698000
March 31, 2023 - 858000

MBIO

Price: $0.56

52 week price:
0.53
7.00

Earnings Per Share: -6.71 USD

P/E Ratio: -0.14

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 169948

Ebitda: -6.9 million

Market Capitalization: 5.3 million

Links: